THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical company ...
Jan. 23—THURSDAY, Jan. 23, 2025 (HealthDay News) — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good ...
French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham.
THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about ... plant in Framingham, Massachusetts. On Jan. 15, 2025 ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts.
(HealthDay News) — The US Food and Drug Administration (FDA) has warned Sanofi about significant ... their Genzyme manufacturing plant in Framingham, Massachusetts. On January 15, a warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results